ALC News and Press, Alcon Inc. From 02/27/23

Fourth quarter 2022 sales of $2.2 billion, up 1%, or 7% constant currency (1) (cc) Full year 2022 sales of $8.7 billion, up 5%, or up 11% cc Full year 2022 diluted EPS of $0.68, down 11%, or up 37% cc; core diluted EPS (2) of $2.24 up 4%, or 23% cc 2023 outlook ref...

Eye care company Alcon ( NYSE: ALC ) has reached a settlement with J&J Surgical Vision on its pending legal proceedings related to femtosecond laser assisted cataract surgery devices. The parties have exchanged cross-licenses of certain intellectual property and other mutually...

Ad Hoc Announcement Pursuant to Art. 53 LR Alcon Inc. ("Alcon") (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that it has entered into a settlement agreement with J&J Surgical Vision, Inc. to resolve their pending legal p...

Alcon ( NYSE: ALC ) said it had launched in Canada its Total30 for  and Dailies Total1 for Astigmatism, a common vision problem. This launch extends Alcon’s portfolio of reusable and daily disposable lenses designed for astigmatic patients. People with astigmatism have...

Introducing TOTAL30 for Astigmatism and DAILIES TOTAL1 for Astigmatism: the first Water Gradient contact lenses for patients with astigmatism New innovations for patients with astigmatism aim to provide brilliant vision and exceptional comfort to the fastest-growing contact lens market se...

Summary A firm creates value when its return on invested capital exceeds its cost of capital. If it doesn't, regardless of its expansion, growth will become destructive to shareholder value. This has been the case for Alcon Inc. over the past few years. Hence, despite a breakout...

Summary The management team at The Cooper Companies released promising financial guidance for the firm's 2023 fiscal year. If the firm can hit guidance, then it may very well make for a decent prospect. But given the uncertainty and forward-looking nature of this guidance, investors...

Summary BMEZ’s portfolio has a combination of unknown small-cap "next generation" healthcare holdings and some familiar names in the field of biotechnology. Lack of diversification makes BMEZ susceptible to sector-specific risk. It also has a relatively high expense ratio despite...

The first reusable, Water Gradient lens for astigmatic contact lens wearers Reusable toric market is greater than $1.2B and growing 1 Commercially available in the U.S. and Europe beginning in early 2023 Alcon (SIX/NYSE: ALC), the global leader in eye care dedicate...

Alcon (SIX/NYSE: ALC) CEO David Endicott will present at the 2023 J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 11:15 a.m. PST. A live webcast of the conference will be available at investor.alcon.com/news-and-events/events-and-presentations . About Alcon ...